PNH and aHUS Market Growth Opportunities Across Global Healthcare Systems
Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS) are rare, life-threatening disorders associated with dysregulation of the complement system. Increasing awareness of rare diseases, growing access to advanced diagnostic tools, and the development of targeted biologic therapies are significantly transforming the treatment landscape. Pharmaceutical companies...
0 Commentaires 0 Parts 358 Vue 0 Aperçu